PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly
NCT00532116 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2007-09-19
Summary
Evaluate the effect of age on the PK of two different doses of EMSAM.
Conditions
- Healthy
Interventions
- DRUG
-
EMSAM (Selegiline Transdermal System) 6mg
STS 6mg/24hr
- DRUG
-
EMSAM (Selegiline Transdermal System) 12mg
EMSAm 12mg/24Hr
Sponsors & Collaborators
-
Somerset Pharmaceuticals
lead INDUSTRY
Study Design
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-04-30
- Completion
- 2007-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting
NCT00418678 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
NCT02155309 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude
NCT03536520 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of TAK-951 in Healthy Adults
NCT05567393 ·Status: COMPLETED ·Phase: PHASE1
-
Ginger Control of Chemotherapy Induced Nausea and Vomiting
NCT00065221 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies
NCT06150469 ·Status: RECRUITING ·Phase: NA
-
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
NCT03988530 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude
NCT03536429 ·Status: COMPLETED ·Phase: PHASE4
-
AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT)
NCT03621722 ·Status: COMPLETED ·Phase: NA
-
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
NCT05611814 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
NCT05221892 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects
NCT06764147 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers
NCT01094821 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide
NCT01069536 ·Status: COMPLETED ·Phase: NA
-
An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant
NCT02285647 ·Status: COMPLETED ·Phase: PHASE1
-
Re-examination Study of EMEND (Aprepitant) (MK-0869-184)
NCT01074255 ·Status: COMPLETED
-
Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness
NCT04272255 ·Status: UNKNOWN ·Phase: PHASE3
-
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT05319860 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
NCT02369107 ·Status: UNKNOWN ·Phase: NA
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting
NCT00360841 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
NCT04184115 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
NCT06511947 ·Status: RECRUITING ·Phase: PHASE1
-
Acupuncture for Chemotherapy-Induced Nausea and Vomiting
NCT02195921 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
NCT02357420 ·Status: COMPLETED ·Phase: PHASE2